Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.77% |
| 2 | Consumer Discretionary | 1.94% |
| 3 | Technology | 1.9% |
| 4 | Communication Services | 1.42% |
| 5 | Financials | 1.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CUTR
9101
CALL
DELISTED
Cutera, Inc.
CUTR
| $593K | ﹤0.01% |
12,100
-16,800
| -58% | -$617K |
|
|
ACOR
9102
PUT
DELISTED
Acorda Therapeutics
ACOR
| $593K | ﹤0.01% |
6,215
-1,465
| -19% | -$128K |
|
|
SWCH
9103
PUT
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $593K | ﹤0.01% |
28,100
-16,800
| -37% | -$322K |
|
9104
WisdomTree US High Dividend Fund
DHS
$1.6B
| $592K | ﹤0.01% |
7,571
-28,932
| -79% | -$2.28M |
|
|
STR
9105
CALL
DELISTED
Sitio Royalties
STR
| $592K | ﹤0.01% |
+29,125
| New | +$559K |
|
9106
PUT
Yext
YEXT
$693M
| $592K | ﹤0.01% |
41,400
-136,300
| -77% | -$1.9M |
|
|
SFE
9107
PUT
DELISTED
Safeguard Scientifics, Inc.
SFE
| $592K | ﹤0.01% |
76,300
-76,900
| -50% | -$524K |
|
|
DBOC
9108
DELISTED
Innovator Double Stacker 9 Buffer ETF - October
DBOC
| $592K | ﹤0.01% |
20,603
-26,284
| -56% | -$747K |
|
|
MAGN
9109
CALL
Magnera Corp
MAGN
$441M
| $591K | ﹤0.01% |
+3,254
| New | +$641K |
|
|
GPP
9110
CALL
DELISTED
Green Plains Partners LP
GPP
| $591K | ﹤0.01% |
46,200
+2,300
| +5% | +$28.1K |
|
|
ICON
9111
DELISTED
Iconix Brand Group, Inc.
ICON
| $591K | ﹤0.01% |
188,878
+92,555
| +96% | +$213K |
|
9112
Adtran
ADTN
$629M
| $590K | ﹤0.01% |
28,595
-26,807
| -48% | -$518K |
|
9113
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.07B
| $590K | ﹤0.01% |
14,682
-6,852
| -32% | -$271K |
|
|
RWT
9114
Redwood Trust
RWT
$580M
| $590K | ﹤0.01% |
48,843
+31,762
| +186% | +$354K |
|
|
VNTR
9115
CALL
DELISTED
Venator Materials PLC
VNTR
| $590K | ﹤0.01% |
124,400
-60,500
| -33% | -$290K |
|
|
DSPG
9116
DELISTED
DSP Group Inc
DSPG
| $590K | ﹤0.01% |
39,871
+27,196
| +215% | +$406K |
|
9117
Federal Signal
FSS
$7.21B
| $589K | ﹤0.01% |
14,637
+6,432
| +78% | +$264K |
|
|
EVLO
9118
CALL
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $589K | ﹤0.01% |
+2,145
| New | +$541K |
|
9119
Aaon
AAON
$6.26B
| $588K | ﹤0.01% |
14,102
-5,884
| -29% | -$259K |
|
9120
Ollie's Bargain Outlet
OLLI
$4.38B
| $588K | ﹤0.01% |
6,991
-1,874
| -21% | -$163K |
|
9121
Pure Cycle
PCYO
$275M
| $588K | ﹤0.01% |
42,533
+22,355
| +111% | +$320K |
|
9122
PUT
Simulations Plus
SLP
$372M
| $588K | ﹤0.01% |
10,700
-4,400
| -29% | -$252K |
|
|
KLRS
9123
Kalaris Therapeutics
KLRS
$95.9M
| $588K | ﹤0.01% |
1,295
-1,815
| -58% | -$937K |
|
9124
Donaldson
DCI
$10.7B
| $587K | ﹤0.01% |
+9,238
| New | +$571K |
|
9125
PUT
Griffon
GFF
$4.48B
| $587K | ﹤0.01% |
22,900
-13,300
| -37% | -$355K |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.